Collect your real-world data with Carebytes

Collect your real-world data with Carebytes

Do you need to collect data for your next reimbursement dossier, your revision dossier or to meet the terms of your managed entry agreement? In partnership with healthcare software developer Carebytes, e&a consultants has designed a real-world data platform, customisable to your needs and with GDPR compliance.

What is the added value of Carebytes?

Carebytes is a web-based platform through which doctors can swiftly and accurately answer questions imposed by the government about your medicine. Compared with conducting clinical studies, this approach is considerably less time-consuming and provides you with an accurate insight into current clinical practices in Belgium. In addition, our platform allows you to collect real-world data in a GDPR-compliant manner. A fast, complete and legally sound way of collecting data, that is Carebytes.

Is your pharma company active outside of Belgium? Carebytes can be used internationally. In that case, we will do a preparatory legal check and carry out the necessary tweaks so you can collect real-world data in your country.

How do we set up the platform?

STEP ZERO – INTERVIEW | We can tailor the Carebytes platform to your needs, but before we do so, we first need to understand those needs. What questions imposed by the government do you want to answer with the platform? During this exploratory interview, we explain how Carebytes works with a demo and consider how we can customise it for you.

STEP ONE – SET UP | Once it’s clear what information you want to acquire via the platform, we prepare a draft of the questionnaire which users will fill out on the platform. We finalise that draft in collaboration with potential users of the platforms (your employees, doctors, and so on) to ensure that the questions are clearly formulated and easy to answer.

STEP TWO – TRAINING | Working closely with healthcare software developer Carebytes, we translate the draft into a demo version of the platform and organise training for doctors who will use it. This is in part to help them understand how the platform works but also to explain why their input is needed for the reimbursement of your medicine.

STEP THREE – DATA COLLECTING |  Finally, your customised version of the platform will go live for a specific time period agreed on in the initial interview. Doctors who need access will receive a registration link via email and will be able to fill out the questionnaire.

Collect your data with GDPR compliance

During your use of the Carebytes platform, you can count on the support of our Data Protection Officer to answer any privacy-related questions and to make sure your data research is fully in compliance with GDPR rules. Furthermore, our platform uses European servers fortified with encryption and anonymisation measures to protect your patients’ data.

We support you after data collection

Need support translating your data into insights for your revision or reimbursement dossier? At e&a consultants, we can extract your data in an aggregated manner, respecting the anonymity of patients, and perform an analysis to draw up a substantiated and accurate dossier.

Are you looking for a real-world data platform? 

Book an exploratory meeting with us to view a demo of the Carebytes platform and learn how our consultants can support you during and after your data research.


Collect your real-world data with Carebytes

e&a in numbers: a look at our achievements

As consultants dedicated to insights and results, "to measure is to know" is more than just a saying for us at e&a – it’s part of our DNA. With this in mind, we’re proud to share our latest year report, highlighting key metrics from 2017 to now.

Read more

Unlocking market access in healthcare & navigating pharmacoeconomics

In today’s ever-evolving healthcare landscape, market access for new medicines and treatments is more complex than ever and pharmacoeconomics has become a critical tool. We sat down to discuss these challenges with our Managing Director Johan Eykens and Philippe Van Wilder from Smart&Bi.

Read more

Introducing our new colleague, Lena!

We’re excited to welcome Lena Dumortier as the latest addition to the e&a consultants team! Joining us as a Market Access Associate Consultant, Lena brings her passion for helping patients and her background in pharmacy.

Read more

Explaining the reformed reimbursement procedure in Belgium

In May 2024, a major reform of medicine reimbursement in Belgium was approved by the Parliament. This reform is now also published into the Belgian Official Gazette. But how will these changes impact pharma companies and patients?

Read more

Partnership in the picture: providing comprehensive support with InfarAMA

To maximise your market success, e&a consultants partners with InfarAMA, expert in regulatory affairs. Johan Eykens sat down with InfarAMA’s managing directors, Marian Coquel and Kristl Vandenbussche, to discuss the partnership’s strengths.

Read more

Market access intern Chloé on her internship at e&a consultants

After nine months, Chloé’s internship at e&a consultants has come to an end, the perfect opportunity for her to look back on the highlights and learnings of this period with her supervisor, Arne.

Read more

It’s official: the reimbursement procedure for medicine will be reformed!

Last week a major reform of the reimbursement procedure for medicine was approved. But what does that mean for you as a patient or for your pharma company? e&a consultants summarises the key points for you.

Read more

e&a consultants introduces pharma students to market access

e&a consultants co-organises an Orientation Day to introduce master pharma students at the KU Leuven to consultancy and other career paths. Why the need for this event? Managing director Johan Eykens and senior associate consultant Lotte Herbots are happy to tell you.

Read more

New colleague in the picture: meet office assistant Elodie

We could never support our clients as well as we do without our top-notch team. Meet our newest colleague, office assistant Elodie Recio Martinez.

Read more

e&a consultants looks back at 2023: new team, new platform, new laws

Managing Director Johan Eykens looks back on 2023, a year full of changes for e&a consultants. What was their greatest milestone in 2023? What are the challenges to come? Find out in this interview.

Read more

We wish you a sparkling 2024

As 2024 approaches, we are filled with excitement. Because along with the new year, a thrilling new chapter for e&a consultants begins.

Read more

{{ popup_title }}

{{ popup_close_text }}

x